Notice of Intent to Award a Sole Source for iCAD AI Mammography Software Licenses

The Indian Health Service (IHS) has a requirement for the renewal and continuation of iCAD 2D/3D Detection Per Exam Licenses for its 3D Mammography (Digital Breast Tomosynthesis) suite. The required service provides an essential Artificial Intelligence (AI) platform that serves as a concurrent reading tool to aid Radiologists in the interpretation of mammogram studies. The service includes critical software upgrades necessary to maintain the system’s diagnostic accuracy and security. The period of performance for this award is anticipated to be one 12-month base period with four 12-month options. • The AI software is a proprietary program owned and developed exclusively by iCAD, Inc. • The existing iCAD cloud service hosts historical patient imaging data (Protected Health Information - PHI). • Migrating this sensitive data to an alternative vendor would present an unacceptable risk of data loss or corruption. • Switching to another source would require a complex, high-risk, and cost-prohibitive data migration project.